27329-40-4

Upstream product

• 51329-15-8 methyl 3,5-dibromobenzoate 
• 67973-19-7 3,5-dibromo-2,6-dinitrobenzoic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 186581-53-3 diazomethane 
• 124-38-9 carbon dioxide 
• 51686-79-4 2,4,6-tribromo-1,3-dinitrobenzene 

Downstream Products

• 1193780-21-0 methyl 2,6-dinitro-3,5-bis[(phenylmethyl)amino]benzoate 
• 1193780-18-5 methyl 3,5-bis(cyclohexylamino)-2,6-dinitrobenzoate 
• 1193780-38-9 methyl 3,5-bis[(cyclopropylmethyl)amino]-2,6-dinitrobenzoate 
• 1193780-26-5 methyl 3,5-bis[(3,3-dimethylbutyl)amino]-2,6-dinitrobenzoate 

Relevant academic research and scientific papers

PROLYL HYDROXYLASE INHIBITORS

The invention described herein relates to certain t?-imidazobenzamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.

Antifungal agents

A method of treating fungal diseases as well as pharmaceutical, veterinary and agricultural compositions useful in such treatment. The method includes administering an effective antifungal amount of a compound of the formula (I): wherein S is a spacer selected from a nitrogen, an oxygen, an alkyl, an alkenyl, an alcohol, an ester, a polyester, an amino acid, a carbohydrate, or a nitrogen-containing positively charged group; L is a ligand selected from a hydrogen, a hydroxyl residue, an alkyl residue, an alkenyl residue, a benzyl residue, an alcohol residue, an ester residue, a polyester residue, an alkyl acid residue, a carbohydrate, a steroid, a lipid, an organic polymer, a nitrogen-containing positively charged group or a vitamin; R1 and R3 are halogen or hydroxyl; and R2 is hydrogen or alkyl.